Multi-Omics Analysis of Tislelizumab Plus Nab-Paclitaxel and Cisplatin as Neoadjuvant Immunochemotherapy for Locally Advanced Hypopharyngeal Squamous Cell Carcinoma: A Prospective Single-Arm Phase 2 Trial

Lin Gui, Zucheng Xie, Wen Zhang, Xinrui Chen, Shaoyan Liu, Xiaolei Wang, Junlin Yi, Changming An, Haizhen Lu, Jiarui Yao, Haohua Zhu, Tongji Xie, Le Tang, Xiaohui He, Yuankai ShiSSRN 2024 · DOI

BibTeX
@misc{gui2024multi,
  author = {Lin Gui and Zucheng Xie and Wen Zhang and Xinrui Chen and Shaoyan Liu and Xiaolei Wang and Junlin Yi and Changming An and Haizhen Lu and Jiarui Yao and Haohua Zhu and Tongji Xie and Le Tang and Xiaohui He and Yuankai Shi},
  title = {{Multi-Omics Analysis of Tislelizumab Plus Nab-Paclitaxel and Cisplatin as Neoadjuvant Immunochemotherapy for Locally Advanced Hypopharyngeal Squamous Cell Carcinoma: A Prospective Single-Arm Phase 2 Trial}},
  year = {2024},
  doi = {10.2139/ssrn.4821010},
  howpublished = {SSRN},
}

Loading related content...

Figure